Structural Biology in Cancer Research

Structural Biology in Cancer Research

The major part of research is being carried out in the area of cancer. The main aim is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modeling mainly aims at drug designing. Eventually, many researchers in Structural biology carry out cancer research to extend the exploitation of molecular understanding of biomolecules in the advancement of novel cancer therapies. Cancer immunotherapy is also used which is defined as the response of immune system to reject cancer. Immunotherapies can be a better way of treating cancer. The malignant tumor cells are attacked by stimulating the immune system as these cells are responsible to exploit the fact that cancer cells often have molecules on their surface that can be detected by the tumor-associated antigens (TAAs).

  • Antibody Therapy

  • Cellular Immunotherapy

  • Cytokine Therapy

  • Combinational Immunotherapy

    Related Conference of Structural Biology in Cancer Research

    March 07-08, 2024

    14th World Glycobiology Congress

    Toronto, Canada
    March 28-29, 2024

    6th International Conference on Biochemistry

    Dubai, UAE
    May 16-17, 2024

    30th Asia Pacific Biotechnology Congress

    Rome, Italy
    September 25-26, 2024

    20th World Congress on Structural Biology

    Paris, France

    Structural Biology in Cancer Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in